From: TNF-α is associated with loss of lean body mass only in already cachectic COPD patients
Yearly change in FFMI | p-value | Yearly change in FMI | p-value | |
---|---|---|---|---|
CRP at baseline | ||||
at CRP = 2.4 | −0.0622 | 0.1355 | ||
per 1 ug/mL increase | 0.0221 | 0.01 | −0.0066 | 0.48 |
Sustained high CRP at year 0 and 1 | ||||
No | −0.0874 | 0.1494 | ||
Yes | 0.0656 | 0.01 | 0.0061 | 0.03 |
TNF-α at baseline | ||||
at TNF-α = 1.8 | −0.0531 | 0.1303 | ||
per 1 pg/mL increase | −0.0098 | 0.13 | 0.0004 | 0.96 |
Sustained high TNF-α at year 0 and 1 | ||||
No | −0.0643 | 0.1287 | ||
Yes | −0.2098 | 0.03 | 0.1366 | 0.91 |
IL-1ß at baseline | ||||
at IL-1ß = 0.93 | −0.0424 | 0.1300 | ||
per 1 pg/mL increase | 0.0147 | 0.16 | 0.0009 | 0.93 |
Sustained high IL-1ß at year 0 and 1 | ||||
No | −0.0685 | 0.1257 | ||
Yes | −0.0341 | 0.58 | 0.1548 | 0.67 |
IL-6 at baseline | ||||
at IL-6 = 2.8 | −0.0414 | 0.1302 | ||
per 1 pg/mL increase | 0.0034 | 0.02 | 0.0004 | 0.79 |
Sustained high IL-6 at year 0 and 1 | ||||
No | −0.0676 | 0.1291 | ||
Yes | 0.0231 | 0.18 | 0.1184 | 0.88 |